Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001193125-25-291731

Director sold 1,300,000 shares at an average $20.23 ($26,304,500)

From the SEC's structured data for this filing

Trades in this filing

Gold Daniel Allen · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-19 Sale : show line 1 in the form −850,000 $20.25 $17,212,500 18,497,727 I
2025-11-19 Sale : show line 2 in the form −150,000 $20.20 $3,030,000 18,347,727 I
2025-11-19 Sale : show line 3 in the form −125,000 $20.16 $2,520,000 18,222,727 I
2025-11-19 Sale : show line 4 in the form −175,000 $20.24 $3,542,000 18,047,727 I
Open-market sales · 1,300,000 sh · avg $20.23 · $26,304,500
Loading xslF345X05/ownership.xml…